DE SCORDILLI, MARCO
DE SCORDILLI, MARCO
DMED - DIPARTIMENTO DI MEDICINA
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva
2020-01-01 Bartoletti, M.; Mazzeo, R.; De Scordilli, M.; Del Fabro, A.; Vitale, M. G.; Bortot, L.; Nicoloso, M. S.; Corsetti, S.; Bonotto, M.; Scalone, S.; Giorda, G.; Sorio, R.; Andreetta, C.; Meacci, M. L.; De Vivo, R.; Fasola, G.; Sopracordevole, F.; Puglisi, F.
Liquid biopsy in colorectal cancer: Onward and upward
2024-01-01 Torresan, S.; de Scordilli, M.; Bortolot, M.; Di Nardo, P.; Foltran, L.; Fumagalli, A.; Guardascione, M.; Ongaro, E.; Puglisi, F.
NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome
2021-01-01 Michelotti, A.; de Scordilli, M.; Palmero, L.; Guardascione, M.; Masala, M.; Roncato, R.; Foltran, L.; Ongaro, E.; Puglisi, F.
NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease
2022-01-01 Michelotti, Anna; DE SCORDILLI, Marco; Bertoli, Elisa; De Carlo, Elisa; Del Conte, Alessandro; Bearz, Alessandra
Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials
2022-01-01 DE SCORDILLI, Marco; Michelotti, Anna; Bertoli, Elisa; De Carlo, Elisa; Del Conte, Alessandro; Bearz, Alessandra
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva | 1-gen-2020 | Bartoletti, M.; Mazzeo, R.; De Scordilli, M.; Del Fabro, A.; Vitale, M. G.; Bortot, L.; Nicoloso, M. S.; Corsetti, S.; Bonotto, M.; Scalone, S.; Giorda, G.; Sorio, R.; Andreetta, C.; Meacci, M. L.; De Vivo, R.; Fasola, G.; Sopracordevole, F.; Puglisi, F. | |
| Liquid biopsy in colorectal cancer: Onward and upward | 1-gen-2024 | Torresan, S.; de Scordilli, M.; Bortolot, M.; Di Nardo, P.; Foltran, L.; Fumagalli, A.; Guardascione, M.; Ongaro, E.; Puglisi, F. | |
| NAFLD-Related Hepatocarcinoma: The Malignant Side of Metabolic Syndrome | 1-gen-2021 | Michelotti, A.; de Scordilli, M.; Palmero, L.; Guardascione, M.; Masala, M.; Roncato, R.; Foltran, L.; Ongaro, E.; Puglisi, F. | |
| NSCLC as the Paradigm of Precision Medicine at Its Finest: The Rise of New Druggable Molecular Targets for Advanced Disease | 1-gen-2022 | Michelotti, Anna; DE SCORDILLI, Marco; Bertoli, Elisa; De Carlo, Elisa; Del Conte, Alessandro; Bearz, Alessandra | |
| Targeted Therapy and Immunotherapy in Early-Stage Non-Small Cell Lung Cancer: Current Evidence and Ongoing Trials | 1-gen-2022 | DE SCORDILLI, Marco; Michelotti, Anna; Bertoli, Elisa; De Carlo, Elisa; Del Conte, Alessandro; Bearz, Alessandra |